Acuson and Advanced Technology Laboratories last week settleda patent dispute between the ultrasound competitors relating tomultiplane transesophageal (TEE) technology and an ultrasoundfocusing technique. The settlement ends lawsuits that had beenfiled
Acuson and Advanced Technology Laboratories last week settleda patent dispute between the ultrasound competitors relating tomultiplane transesophageal (TEE) technology and an ultrasoundfocusing technique. The settlement ends lawsuits that had beenfiled last year in federal courts in Washington and California.
ATL had claimed that Acuson was infringing on its TEE patents,while Acuson charged ATL will violating its patent for an ultrasoniclens with reduced delay range. As part of the settlement, Acusonagreed to pay ATL an undisclosed sum in royalty payments on TEEprobes it sells. The companies entered a cross-licensing agreementfor several patents, including the Acuson focusing patent.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.